FEDERATED HERMES, INC.

Position in OVID — Ovid Therapeutics Inc.

CIK 1056288 PITTSBURGH, PA

Position in OVID

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$16,009,981

+$8,082,361 QoQ

Shares Held

5,951,666

+66.7% QoQ

Ownership

3.05%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#11

of 130 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. OVID ranks #39 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	719,905	$216,713,000
2	RYTM	Rhythm Pharmaceuticals, Inc.	1,785,716	$198,268,046
3	REGN	Regeneron Pharmaceuticals, Inc.	256,884	$160,177,448
4	MRNA	Moderna, Inc.	1,794,778	$125,688,301
5	KYMR	Kymera Therapeutics, Inc.	749,398	$85,933,468
6	EYPT	EyePoint, Inc.	5,681,052	$81,239,042
7	ARGX	Argenx SE	87,288	$80,983,187
8	ZBIO	Zenas BioPharma, Inc.	3,116,805	$79,104,510

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$16,009,981	5,951,666	+66.7%	Shares	Defined	2026-08-12
2026-06-30	$20,812,976	7,737,166	—	Shares	Sole	2026-07-08
2026-03-31	$7,927,620	3,571,000	0.0%	Shares	Defined	2026-05-11
2025-12-31	$5,820,730	3,571,000	+158611.1%	Shares	Defined	2026-02-12
2024-06-30	$1,730	2,250	+19.2%	Shares	Defined	2024-08-08
2021-12-31	$6,057	1,887	+53.3%	Shares	Defined	2022-02-14
2021-09-30	$4,136	1,231	+392.4%	Shares	Defined	2021-11-15
2021-06-30	$977	250	-48.2%	Shares	Defined	2021-08-16
2020-12-31	$1,115	483	-78.6%	Shares	Defined	2021-02-12
2020-09-30	$12,960	2,258	+921.7%	Shares	Defined	2020-11-12
2020-06-30	$1,628	221	-0.5%	Shares	Defined	2020-08-13
2020-03-31	$661	222	—	Shares	Defined	2020-05-13
No filing history on record for this holder in this stock.